Sugi Predict

Sugi Predict / Compounds / SCHEMBL2031163

SCHEMBL2031163

SCHEMBL2031163

Fc1c(Br)cccc1OC(F)F

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DRD1 P21728 1/20 0.35
▸ TNF P01375 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ POLB P06746 1/20 0.33
▸ SLC6A2 P23975 4/20 0.31
▸ SLC6A4 P31645 4/20 0.31
▸ KCNH2 Q12809 3/20 0.31
▸ SLC6A3 Q01959 3/20 0.31
▸ KCNN4 O15554 2/20 0.31
▸ LMNA P02545 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29867899 1.00 HTT (0.41) HTTKMT2AMEN1SMN1; SMN2DRD1
SCHEMBL29512010 0.83 DRD1 (0.44) HTTKMT2AMEN1SMN1; SMN2DRD1
SCHEMBL2224833 0.82 MCHR1 (0.39) HTTKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL16035613 0.81 KDM1A (0.33) HTTKMT2AMEN1SMN1; SMN2KCNH2
SCHEMBL29470879 0.81 KDM1A (0.33) HTTKMT2AMEN1SMN1; SMN2KCNH2
SCHEMBL29819809 0.80 DRD1 (0.42) HTTKMT2AMEN1SMN1; SMN2DRD1
SCHEMBL264299 0.80 DRD1 (0.42) HTTKMT2AMEN1SMN1; SMN2DRD1
SCHEMBL23588427 0.78 SLC6A2 (0.48) HTTKMT2ASMN1; SMN2DRD1ALDH1A1
SCHEMBL18246234 0.78 DRD1 (0.39) HTTKMT2AMEN1SMN1; SMN2DRD1
SCHEMBL25435045 0.78 ALDH1A1 (0.42) HTTKMT2AMEN1SMN1; SMN2DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166645-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2024-05-23 — — US disclosed
WO-2024099269-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, USE THEREOF 华东师范大学 2024-05-16 — — WO disclosed
CN-118026880-A Aryl amide compound, pharmaceutical composition containing same and application thereof 华东师范大学 2024-05-14 — — CN disclosed
EP-4289843-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2023-12-13 — — EP disclosed
EP-4289843-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2023-12-13 — — EP disclosed
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 — — US disclosed
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 — — US disclosed
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 — — US disclosed
CN-114907341-A Pyridopyrimidinone derivatives, and preparation method and application thereof 武汉人福创新药物研发中心有限公司 2022-08-16 — — CN disclosed
WO-2022166974-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 武汉人福创新药物研发中心有限公司 2022-08-11 — — WO disclosed
CN-113784950-A Novel thyromimetic agents 速通医疗公司 2021-12-10 — — CN disclosed
US-20210053917-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2021-02-25 — — US disclosed
US-20210053917-A1 NOVEL THYROMIMETICS AUTOBAHN THERAPEUTICS, INC. 2021-02-25 — — US disclosed
US-10864211-B2 Hydroxy isoxazole compounds useful as GPR120 agonists MERCK SHARP & DOHME CORP. (US) 2020-12-15 — — US disclosed
EP-3555055-A1 HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS Merck Sharp & Dohme Corp. (US) 2019-10-23 — — EP disclosed
US-20190269679-A1 HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS MERCK SHARP & DOHME CORP. (US) 2019-09-05 — — US disclosed
WO-2018111734-A1 HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-06-21 — — WO disclosed
WO-2018107415-A1 HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS MERCK SHARP & DOHME CORP. (US) 2018-06-21 — — WO disclosed
WO-2011076687-A1 PYRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-30 — — WO disclosed
WO-2011076687-A1 PYRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR HTT 536/4885KMT2A 4284/4885MEN1 183/4885
US-20240166645-A1 PYRIDOPYRIMIDINONE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF SOS1, WEE1, SOS2 HTT 4619/4885KMT2A 4428/4885MEN1 434/4885
US-10864211-B2 Hydroxy isoxazole compounds useful as GPR120 agonists GPR119, GPR88, GPR180 HTT 2645/4885KMT2A 3678/4885MEN1 4799/4885
US-20210053917-A1 NOVEL THYROMIMETICS TPO, TSHR, CHRM1 HTT 508/4885KMT2A 4427/4885MEN1 254/4885
US-20190269679-A1 HYDROXY ISOXAZOLE COMPOUNDS USEFUL AS GPR120 AGONISTS GPR119, GPR88, GPR180 HTT 2645/4885KMT2A 3678/4885MEN1 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.